Canaccord Genuity analyst Caitlin Cronin has maintained their bullish stance on KRMD stock, giving a Buy rating yesterday. Caitlin Cronin has given his Buy rating due to a combination of factors ...
Repro MedSystems is executing a significant strategic shift, moving beyond its traditional core business. The company is ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results